✦ LIBER ✦

An effective oral antiemetic regimen for patients on Cyclophosphamide+Adriamycin+Vincristine (CAV) for small cell lung cancer (SCLC)

Book ID: 122852714
Publisher: Elsevier Science
Year: 1986
Tongue: English
Weight: 91 KB
Volume: 2
Category: Article
ISSN: 0169-5002
DOI: 10.1016/S0169-5002(86)80652-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Alternating chemotherapy of cyclophospha

Alternating chemotherapy of cyclophosphamide + adriamycin + vincristine(CAV)--cisplatin + etoposide(PVP) for small cell lung cancer

📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 116 KB

Daily oral cyclophosphamide for patients

Daily oral cyclophosphamide for patients with small cell lung cancer (SCLC) unsuitable for standard treatment. A phase I/II study

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 151 KB

Effect of alternating combination chemot

Effect of alternating combination chemotherapy consisting of cyclophosphamide, doxorubicin, vincristine, cisplatin, and etoposide for small cell lung cancer on hematopoietic progenitors in the peripheral blood

✍ Shimizu, E; Yamamoto, A; Takahashi, Y; Maniwa, K; Yoshida, S; Mukai, J; Takaue, 📂 Article 📅 1993 🏛 Nature Publishing Group 🌐 English ⚖ 669 KB

P11. Developing an immunotherapy strateg

P11. Developing an immunotherapy strategy for the effective treatment of patients with Non Small Cell Lung Cancer (NSCLC): strategies to evaluate immunity in patients on clinical trials

✍ Neuberger, M; Paustian, C; Hilton, T; Engel, N; Reu, S; Linder, A; Huber, R; Hat 📂 Article 📅 2014 🏛 Springer (Biomed Central Ltd.) 🌐 English ⚖ 80 KB